D
Esperion Therapeutics, Inc. ESPR
$1.50 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue 33.86% -30.07%
Total Other Revenue -- --
Total Revenue 33.86% -30.07%
Cost of Revenue 32.24% 2.26%
Gross Profit 35.73% -48.79%
SG&A Expenses -7.63% -9.53%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 8.68% -5.05%
Operating Income 72.42% -721.40%
Income Before Tax 27.79% 52.32%
Income Tax Expenses -- --
Earnings from Continuing Operations 27.79% 52.32%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 27.79% 52.32%
EBIT 72.42% -721.40%
EBITDA 72.54% -719.20%
EPS Basic 28.05% 53.81%
Normalized Basic EPS 33.69% -228.82%
EPS Diluted 28.05% 53.81%
Normalized Diluted EPS 33.69% -228.82%
Average Basic Shares Outstanding 0.33% 3.25%
Average Diluted Shares Outstanding 0.33% 3.25%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings